Our study suggested that the balance between vasodilator and vasoconstrictor metabolites of arachidonic acid is disturbed in obesity and is regulated by increased TRPC5 and activated cPLA2. Here, TRPC5 is linked to obesity due to melanocortin 4 receptor deficiency.